Neurocrine Biosciences Inc (NBIX)
117.43
-5.44
(-4.43%)
USD |
NASDAQ |
Nov 15, 16:00
117.22
-0.21
(-0.18%)
After-Hours: 20:00
Neurocrine Biosciences Total Return Level: 122.88 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 14, 2024 | 122.88 |
| November 13, 2024 | 125.51 |
| November 12, 2024 | 127.01 |
| November 11, 2024 | 127.17 |
| November 08, 2024 | 125.74 |
| November 07, 2024 | 123.98 |
| November 06, 2024 | 125.30 |
| November 05, 2024 | 121.53 |
| November 04, 2024 | 120.53 |
| November 01, 2024 | 122.21 |
| October 31, 2024 | 120.27 |
| October 30, 2024 | 124.33 |
| October 29, 2024 | 116.19 |
| October 28, 2024 | 116.20 |
| October 25, 2024 | 116.08 |
| October 24, 2024 | 115.52 |
| October 23, 2024 | 115.08 |
| October 22, 2024 | 116.78 |
| October 21, 2024 | 116.57 |
| October 18, 2024 | 118.01 |
| October 17, 2024 | 118.46 |
| October 16, 2024 | 118.35 |
| October 15, 2024 | 117.34 |
| October 14, 2024 | 116.44 |
| October 11, 2024 | 115.49 |
| Date | Value |
|---|---|
| October 10, 2024 | 112.41 |
| October 09, 2024 | 111.62 |
| October 08, 2024 | 111.66 |
| October 07, 2024 | 112.16 |
| October 04, 2024 | 114.00 |
| October 03, 2024 | 111.88 |
| October 02, 2024 | 113.95 |
| October 01, 2024 | 114.15 |
| September 30, 2024 | 115.22 |
| September 27, 2024 | 115.06 |
| September 26, 2024 | 115.93 |
| September 25, 2024 | 114.55 |
| September 24, 2024 | 116.49 |
| September 23, 2024 | 117.75 |
| September 20, 2024 | 118.35 |
| September 19, 2024 | 120.46 |
| September 18, 2024 | 119.85 |
| September 17, 2024 | 122.31 |
| September 16, 2024 | 122.25 |
| September 13, 2024 | 122.25 |
| September 12, 2024 | 121.28 |
| September 11, 2024 | 121.47 |
| September 10, 2024 | 119.10 |
| September 09, 2024 | 120.64 |
| September 06, 2024 | 120.17 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
72.45
Minimum
Jan 27 2022
153.15
Maximum
Aug 01 2024
107.59
Average
104.00
Median
Oct 21 2021
Total Return Level Benchmarks
| Repligen Corp | 142.43 |
| West Pharmaceutical Services Inc | 634.48 |
| Bruker Corp | 56.42 |
| The Cooper Companies Inc | 108.77 |
| Integra Lifesciences Holdings Corp | 23.27 |